A 32-year-old woman with Stage IV endometriosis (revised ASRM scoring, dense posterior cul-de-sac adhesions, bilateral endometriomas) undergoes IVF. Which finding has the highest evidence for impairing IVF outcomes in endometriosis?
- A Endometriomas > 3 cm reduce ovarian response to stimulation and implantation rates ✓
- B Deep infiltrating endometriosis (DIE) of the recto-sigmoid causes sperm dysfunction
- C Stage IV endometriosis uniformly mandates surgical excision before IVF to improve live birth rates
- D GnRH agonist pre-treatment for 3–6 months prior to IVF has no benefit in endometriosis-associated infertility
Explanation
Endometriomas > 3 cm are associated with reduced ovarian reserve (lower AMH, AFC), impaired response to controlled ovarian stimulation, and reduced oocyte and embryo quality, thereby decreasing IVF success rates. Evidence shows ovarian surgery for endometriomas further reduces ovarian reserve; the decision to operate must weigh risk against benefit. GnRH agonist pre-treatment (3–6 months) before IVF in endometriosis has evidence (Cochrane review) for improving clinical pregnancy rates by approximately four-fold. Stage IV endometriosis does not uniformly require surgery before IVF.
Reference: Shaw's Textbook of Gynaecology, 17th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.